Clinical trial · Interventional
Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
Impact of Adapted Aesthetic Onco in Patients With Cancer of the Upper Aero-digestive Tract During Their Management [ŒUVRE (Adapted Aesthetic Onco Aero-digestive Tract)]
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image. Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive. This study will assess the feasibility of oncoesthetics and describe any obstacles.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Aerodigestive Tract Cancer | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
| Suportive Care | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Adapted Onco-Esthetics sessions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Three sessions of Adapted Onco-Esthetics
- description
- Patients will received three sessions of Adapted Onco-Esthetics
- interventionNames
- Other: Adapted Onco-Esthetics sessions
Primary outcomes (1)
- measure
- Evaluate, in patients treated for cancer of the upper aerodigestive tract, the impact of early treatment with Adapted Onco-Esthetics
- timeFrame
- At each session (first , second and third). An interval of one to 4 weeks between 2 sessions is permitted
- description
- Evaluation of the proportion of patients reporting no worsening of self-image representation, as measured by the BIS body image scale.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient aged 18 or over * Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus. * Patient due to start oncological treatment (recurrence authorized) * Patient fluent in French. * Affiliation with a social security scheme * Signature of informed consent prior to any specific procedure linked to the study * Treatment with curative intent Exclusion Criteria: * Breast-feeding or pregnant patient * Any associated medical or psychological condition that could compromise the patient's ability to participate in the study * Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent. * Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
References
Publications (0)
Data not yet available